Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients
Bárbara Balandín, D. Ballesteros, Rafael Ruiz de Luna, Loreto López-Vergara, Vicente Pintado, Milagros Sancho-González, Cruz Soriano, María José Pérez-Pedrero, Maria José Asensio-Martín, I. Fernández, Diego Rodríguez, José Alberto Silva, Marta Chicot, Reyes Iranzo, Fernando Martínez‐Sagasti, Ana Royuela
Topics & Concepts
Critically illPseudomonas aeruginosaMedicineGram-negative bacterial infectionsIntensive care medicineTazobactamMicrobiologyAntibioticsBacteriaBiologyPiperacillinGeneticsAntibiotic Resistance in BacteriaNosocomial Infections in ICUAntibiotics Pharmacokinetics and Efficacy